The Longitudinal Molecular Monitoring Layer for Oncology
At low tumor burden, detection is limited by sampling frequency - not assay sensitivity.
At low tumor burden, detection is limited by sampling frequency - not assay sensitivity.
Molecular monitoring from whole blood for treatment response and recurrence detection.
Beginning with lung cancer MRD.
info@lbxbio.com